Drawing for STAZOLVI

USPTO serial 79175636

STAZOLVI

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ROACH, APRIL K
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with STAZOLVI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

MAURY M TEPPER III TEPPER & EYSTER PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibioticsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2017FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 25, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 25, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 5, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 5, 2017OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 16, 2016DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 15, 2016DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 25, 2016MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Aug 25, 2016ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Aug 25, 2016OP.TOPPOSITION TERMINATED NO. 999999—
Aug 25, 2016OP.SOPPOSITION SUSTAINED NO. 999999—
May 30, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 30, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 27, 2016RFNPREFUSAL PROCESSED BY IB—
May 20, 2016OP.IOPPOSITION INSTITUTED NO. 999999—
May 12, 2016OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
May 12, 2016OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Feb 11, 2016ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 12, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 24, 2015NPUBNOTICE OF PUBLICATION—
Dec 7, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 4, 2015DOCKASSIGNED TO EXAMINER—
Nov 17, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 12, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 10, 2015LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 7, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance